We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELME
1876
Elme Communities
ELME
$144M
| $385K | ﹤0.01% |
16,728
-2,629
| -14% | -$72.3K |
|
1877
Ooma
OOMA
$604M
| $381K | ﹤0.01% |
27,463
+17,370
| +172% | +$252K |
|
|
SRNE
1878
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $380K | ﹤0.01% |
158,496
-106,162
| -40% | -$347K |
|
|
INN
1879
Summit Hotel Properties
INN
$700M
| $377K | ﹤0.01% |
38,774
+13,762
| +55% | +$156K |
|
|
PRO
1880
DELISTED
PROS Holdings
PRO
| $376K | ﹤0.01% |
11,984
+3,727
| +45% | +$118K |
|
1881
Artivion
AORT
$1.32B
| $375K | ﹤0.01% |
13,209
| – | – |
|
|
MRT
1882
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $375K | ﹤0.01% |
54,878
-77,463
| -59% | -$607K |
|
1883
Bread Financial
BFH
$4.38B
| $373K | ﹤0.01% |
3,115
-1,405
| -31% | -$220K |
|
|
CXP
1884
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $371K | ﹤0.01% |
19,172
+2,850
| +17% | +$61.1K |
|
|
ECHO
1885
DELISTED
Echo Global Logistics, Inc.
ECHO
| $371K | ﹤0.01% |
18,243
-28,455
| -61% | -$710K |
|
1886
VICI Properties
VICI
$29.4B
| $370K | ﹤0.01% |
19,724
-36,664
| -65% | -$771K |
|
|
KYNB
1887
Kyntra Bio
KYNB
$29.4M
| $369K | ﹤0.01% |
319
-1,454
| -82% | -$1.63M |
|
|
RFP
1888
DELISTED
Resolute Forest Products Inc.
RFP
| $369K | ﹤0.01% |
46,534
-22,116
| -32% | -$244K |
|
|
COOP
1889
DELISTED
Mr. Cooper
COOP
| $368K | ﹤0.01% |
+31,560
| New | +$451K |
|
|
ARRS
1890
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $368K | ﹤0.01% |
+12,048
| New | +$335K |
|
|
CIVI
1891
DELISTED
Civitas Solutions, Inc.
CIVI
| $368K | ﹤0.01% |
21,026
-83,806
| -80% | -$1.25M |
|
|
LGTY
1892
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $367K | ﹤0.01% |
+35,124
| New | +$388K |
|
1893
Vanda Pharmaceuticals
VNDA
$302M
| $366K | ﹤0.01% |
+13,995
| New | +$329K |
|
1894
Rexford Industrial Realty
REXR
$8.19B
| $365K | ﹤0.01% |
12,380
-4,597
| -27% | -$146K |
|
1895
Northwest Natural Holdings
NWN
$2.12B
| $363K | ﹤0.01% |
6,007
-11
| -0.2% | -$735 |
|
1896
BioCryst Pharmaceuticals
BCRX
$2.4B
| $361K | ﹤0.01% |
+44,685
| New | +$347K |
|
1897
Coherus Oncology
CHRS
$196M
| $357K | ﹤0.01% |
+39,425
| New | +$456K |
|
1898
Noodles & Co
NDLS
$107M
| $356K | ﹤0.01% |
6,364
+234
| +4% | +$17.4K |
|
|
ELGX
1899
DELISTED
Endologix Inc
ELGX
| $356K | ﹤0.01% |
+49,695
| New | +$553K |
|
1900
Carriage Services
CSV
$569M
| $355K | ﹤0.01% |
22,890
-4,293
| -16% | -$75.2K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.